IQuity releases diagnostic for the chronic musculoskeletal pain syndrome

Nashville-based data science company IQuity has unveiled a groundbreaking new blood test that uses RNA analysis to help practitioners detect fibromyalgia in patients with 94% accuracy, according to a company release.1 Called IsolateFibromyalgia, the test results can be delivered back to the healthcare practitioner within one week, reducing the months or sometimes years it may normally take to diagnose the disease.

“Living with the pain of fibromyalgia is often compounded with confusion and uncertainty when patients don’t know the cause of their illness,” said Chase Spurlock, PhD, chief executive officer of IQuity, in a press release. “IsolateFibromyalgia provides useful information that improves the efficiency of the diagnostic process for doctors.”

Read more of this article from Journal of Practical Pain Management